What's breaking now, across thousands of outlets.
AbbVie is entering a new chapter of growth, fueled by its blockbuster immunology drugs and expanding neuroscience business. Investor Kevin Simpson shares why he's optimistic.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.
Key PointsCoinbase already offered variable-rate Bitcoin-backed loans, and it recently launched a fixed-rate loan option as well.
WASHINGTON — U.S. President Donald Trump on Monday announced a $1 million reward for information about voter fraud, in a fresh bid to sow doubt ahead of the U.S.
The Central Board of Indirect Taxes and Customs has issued clarifications regarding GST registration requirements for businesses.
The number of families that are caught in the inheritance tax next is expected to spike in the coming years due to a crucial change in the rules.
The stocks listed here all have excellent fundamentals and are trading within 10% of their 52-week lows.
Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases.
